Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Patterns of Rehabilitation After Spinal Cord Injury

NCT07865338 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-10-06
Last updated
2026-10-08

Condition(s) studied

Spinal Cord Injury

Study summary

Patients with spinal cord injuries typically achieve a level of independence that allows them to return to their daily lives through an acute-phase rehabilitation program. However, in our country, it has been observed that many patients continue to make multiple hospital visits for rehabilitation purposes even in the later stages following a spinal cord injury, resulting in prolonged hospital stays. This situation negatively affects both the patients' social lives and their financial situations. Additionally, it places a burden on rehabilitation centers.

The aim of this study is to examine the length of hospital stays and the time it takes for patients to return to their daily lives as they continue rehabilitation following a spinal cord injury.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Be under follow-up for a spinal cord injury * Be 18 years of age or older Exclusion Criteria: * Presence of a neurological condition other than a spinal cord injury * Presence of a psychiatric condition * Cognitive impairment that impairs communication

Primary outcome measure(s)

  • The patient's hospital stays for rehabilitation purposes, as well as the number of centers they visited — at hospital admission

Trial sites (1)

FacilityCityRegionStatus
Gaziler Physical Therapy and Rehabilitation Training and Research Hospital Ankara Çankaya Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07865338 on ClinicalTrials.gov ↗ ← All trials in Turkey